Terms: = Sarcomas AND SOX2, MGC2413, 6657, ENSG00000181449, MCOPS3, P48431, ANOP3 AND Prognosis
18 results:
1. Self-Renewal and Pluripotency in Osteosarcoma Stem Cells' Chemoresistance: Notch, Hedgehog, and Wnt/β-Catenin Interplay with Embryonic Markers.
Martins-Neves SR; Sampaio-Ribeiro G; Gomes CMF
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176108
[TBL] [Abstract] [Full Text] [Related]
2. The value of sox2 in the differential diagnosis of SMARCA4 (BRG1)-deficient uterine neoplasms.
Zheng L; Zhang L; Wang XI; Katz G; Tandon N; Zhao B; Lucci J; Ding J; Zhang S
Hum Pathol; 2022 Jun; 124():45-55. PubMed ID: 35331811
[TBL] [Abstract] [Full Text] [Related]
3. The emerging role of lncRNAs in the regulation of osteosarcoma stem cells.
Song XJ; Bi MC; Zhu QS; Liu XL
Eur Rev Med Pharmacol Sci; 2022 Feb; 26(3):966-974. PubMed ID: 35179763
[TBL] [Abstract] [Full Text] [Related]
4. High Frequency of Tumor Propagating Cells in Fusion-Positive Rhabdomyosarcoma.
Generali M; Satheesha S; Bode PK; Wanner D; Schäfer BW; Casanova EA
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573355
[TBL] [Abstract] [Full Text] [Related]
5. Acquisition of cancer stem cell properties in osteosarcoma cells by defined factors.
Fujiwara S; Kawamoto T; Kawakami Y; Koterazawa Y; Hara H; Takemori T; Kitayama K; Yahiro S; Kakutani K; Matsumoto T; Matsushita T; Niikura T; Koyanagi-Aoi M; Aoi T; Kuroda R; Akisue T
Stem Cell Res Ther; 2020 Oct; 11(1):429. PubMed ID: 33008481
[TBL] [Abstract] [Full Text] [Related]
6. TGF-β is associated with poor prognosis and promotes osteosarcoma progression
Ma K; Zhang C; Li W
Cell Cycle; 2020 Sep; 19(18):2327-2339. PubMed ID: 32804027
[TBL] [Abstract] [Full Text] [Related]
7. Proline‑rich polypeptide‑1 decreases cancer stem cell population by targeting BAFF chromatin‑remodeling complexes in human chondrosarcoma JJ012 cells.
Moran A; Hoyt A; Sedani A; Granger C; Saigh S; Blonska M; Zhao-Ju L; Conway SA; Pretell J; Brown J; Galoian K
Oncol Rep; 2020 Jul; 44(1):393-403. PubMed ID: 32627042
[TBL] [Abstract] [Full Text] [Related]
8. SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Review of Literature.
Stewart BD; Kaye F; Machuca T; Mehta HJ; Mohammed TL; Newsom KJ; Starostik P
Int J Surg Pathol; 2020 Feb; 28(1):102-108. PubMed ID: 31382829
[TBL] [Abstract] [Full Text] [Related]
9. [SMARCA4-deficient primary thoracic sarcoma:a clinicopathological analysis of five cases].
Zheng MJ; Zheng Q; Wang Y; Shen L; Zhu XZ; Li Y
Zhonghua Bing Li Xue Za Zhi; 2019 Jul; 48(7):537-542. PubMed ID: 31288309
[No Abstract] [Full Text] [Related]
10. miR-34a exerts as a key regulator in the dedifferentiation of osteosarcoma via PAI-1-sox2 axis.
Zhang Y; Pan Y; Xie C; Zhang Y
Cell Death Dis; 2018 Jul; 9(7):777. PubMed ID: 29991717
[TBL] [Abstract] [Full Text] [Related]
11. SMARCA4-deficient thoracic sarcoma: a distinctive clinicopathological entity with undifferentiated rhabdoid morphology and aggressive behavior.
Sauter JL; Graham RP; Larsen BT; Jenkins SM; Roden AC; Boland JM
Mod Pathol; 2017 Oct; 30(10):1422-1432. PubMed ID: 28643792
[TBL] [Abstract] [Full Text] [Related]
12. Sarcomatoid adrenocortical carcinoma: a comprehensive pathological, immunohistochemical, and targeted next-generation sequencing analysis.
Papathomas TG; Duregon E; Korpershoek E; Restuccia DF; van Marion R; Cappellesso R; Sturm N; Rossi G; Coli A; Zucchini N; Stoop H; Oosterhuis W; Ventura L; Volante M; Fassina A; Dinjens WN; Papotti M; de Krijger RR
Hum Pathol; 2016 Dec; 58():113-122. PubMed ID: 27589897
[TBL] [Abstract] [Full Text] [Related]
13. Inhibition of sox2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
[TBL] [Abstract] [Full Text] [Related]
14. Identification and analysis of CXCR4-positive synovial sarcoma-initiating cells.
Kimura T; Wang L; Tabu K; Tsuda M; Tanino M; Maekawa A; Nishihara H; Hiraga H; Taga T; Oda Y; Tanaka S
Oncogene; 2016 Jul; 35(30):3932-43. PubMed ID: 26640147
[TBL] [Abstract] [Full Text] [Related]
15. Anoikis-resistant subpopulations of human osteosarcoma display significant chemoresistance and are sensitive to targeted epigenetic therapies predicted by expression profiling.
Foley JM; Scholten DJ; Monks NR; Cherba D; Monsma DJ; Davidson P; Dylewski D; Dykema K; Winn ME; Steensma MR
J Transl Med; 2015 Apr; 13():110. PubMed ID: 25889105
[TBL] [Abstract] [Full Text] [Related]
16. Sphere-forming cell subsets with cancer stem cell properties in human musculoskeletal sarcomas.
Salerno M; Avnet S; Bonuccelli G; Eramo A; De Maria R; Gambarotti M; Gamberi G; Baldini N
Int J Oncol; 2013 Jul; 43(1):95-102. PubMed ID: 23636271
[TBL] [Abstract] [Full Text] [Related]
17. TSSC3 overexpression reduces stemness and induces apoptosis of osteosarcoma tumor-initiating cells.
Huang Y; Dai H; Guo QN
Apoptosis; 2012 Aug; 17(8):749-61. PubMed ID: 22610481
[TBL] [Abstract] [Full Text] [Related]
18. Salinomycin inhibits osteosarcoma by targeting its tumor stem cells.
Tang QL; Zhao ZQ; Li JC; Liang Y; Yin JQ; Zou CY; Xie XB; Zeng YX; Shen JN; Kang T; Wang J
Cancer Lett; 2011 Dec; 311(1):113-21. PubMed ID: 21835542
[TBL] [Abstract] [Full Text] [Related]
